Skip to main content

Find Clinical Trials

Home
Conditions
Liver Cancer (Fibrolamellar Hepatocellular Cancer (FLC))

Clinical trial condition

Liver Cancer (Fibrolamellar Hepatocellular Cancer (FLC))

Explore clinical trials studying Liver Cancer (Fibrolamellar Hepatocellular Cancer (FLC)). Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Liver Cancer (Fibrolamellar Hepatocellular Cancer (FLC)) trial results

Not Yet Recruiting

A DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Glutamine Antagonist DRP-104, Nivolumab, and Ipilimumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC)

NCT07430202

Conditions: Carcinoma, Digestive System Diseases, Digestive System Neoplasms, +8 more
Locations: Johns Hopkins SKCCC Baltimore, Maryland, United States

View Trial Details